Why Should You Attend:
Compliance with the previous Annex 18 regulations for active pharmaceutical ingredients (APIs), EU GMP Part I, was on a voluntary basis and was in line with the EU’s agreement to ICH Q7A guidance. Since 2004 Article 46(f) of Directive 2001/83/EC and Article 50 of Directive2001/83/EC, as amended by Directives 2004/27/EC and 2004/28/EC respectively, mandate manufacturing authorisation holders to only use active substances that have been manufactured according to Good Manufacturing Practice for starting materials. This was then broadened to include excipients, therefore, the course includes requirements from the Joint IPEC-PQG Good Manufacturing Practices Guide for Pharmaceutical Excipients (2006).
This webinar is designed for quality professionals who may or may not have external auditing experience to give a thorough background on auditing suppliers of excipients and active pharmaceutical ingredients (APIs) to the pharmaceutical industry. It will further provide guidance on consistent reporting of findings and will emphasize the differences from regular final drug product auditing.
This webinar is geared towards those taking part in supplier audits for the first time, as well as more experienced auditors with a good manufacturing practice (GMP) or wider GxP background.
Areas Covered in the Webinar:
Who Will Benefit:
Madeleine S. Fairweather Ph.D., MRSB, currently works as an independent auditor and training consultant in GxPs, and as part-time Regulatory Standards Manager for Labcold Ltd., UK, who specialize in the manufacture of blood banks, plasma freezers and pharmacy refrigerators. Her background is in manufacture and supply of biological-based APIs such as therapeutic antibodies and anti-toxins derived from fresh-frozen plasma, as well as recombinant DNA vaccines.
Ms. Fairweather has been involved in technology transfer and ongoing auditing of API suppliers for over ten years which took her to the US, Australasia and Asia. She has successfully ensured the manufacturing quality of products and guided suppliers to achieving their MHRA, FDA and TGA licenses. Further API and excipient experience has been gained through auditing for OTC medicines and antibiotics.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
PAYMENT METHOD: 100% Secure Transaction